














































































Supplementary Figure 1. The ctgfacareg:EGFP transgenic reporter is transiently activated in 
the peri-injured myocardium during heart regeneration.
(a-h) Immunofluorescence staining of ctgfacareg:EGFP transversal heart sections with antibodies 
against GFP (green) and embCMHC (red) at different time points after cryoinjury. The intact 
myocardium is detected by F-actin staining (Phalloidin, blue). (a-b) In uninjured ventricle, 
ctgfacareg:EGFP is expressed in a fine layer in the subcortical myocardium. No embCMHC is 
observed. (c-d) At 4 dpci, ctgfacareg:EGFP is induced in trabecular fascicles abutting the 
post-infarcted area, a subset of which also displays embCMHC expression. (e-f) At 7 dpci, 
ctgfacareg:EGFP expression is maintained at the injury border covering embCMHC+ CMs. (g-h) At 
30 dpci, ctgfacareg:EGFP is reduced to a small margin around the remaining fibrotic tissue. (i) 
Quantification of ctgfacareg:EGFP+ and embCMHC+ area within 100 μm from the injury border. N 
≥ 8.
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Supplementary Figure 2. Peri-injury tissue of the fin stump transiently induces 
ctgfacareg:EGFP expression
(a-l) Live imaging of ctgfacareg:EGFP fins at different days post-amputation (dpa). Higher 
magnifications of framed areas show the region of the amputation plane (yellow dashed line). N=4.
(m-n) Immunofluorescence staining of longitudinal ctgfacareg:EGFP fin sections at 3 dpa. EP, 
epidermis; Ost, osteoblasts; MES, mesenchmyme. (m) ctgfacareg:EGFP is detected in the stump 
mesenchyme and osteoblasts (red) below the amputation plane (dashed line), and in the proximal 
blastema. (n) The mesenchyme of the regenerating fin abundantly expresses Tenascin C, a tissue 
remodelling extracellular protein. N≥4.



































Supplementary Figure 3. careg:dmKO2 is transiently expressed in the peri-injured 
myocardium during heart regeneration.
(a-j) Immunofluorescence staining of careg:dmKO2;cmlc2:EGFP heart sections labelled with 
antibodies against GFP (cardiac cells, blue) and embCMHC (green) at different time points after 
cryoinjury. N=4. (a-b) At 4 dpci, careg:dmKO2+ CMs emerge along the wound margin. (c-f) At 7 
and 14 dpci, a large proportion of careg:dmKO2+ CMs activates the expression of embCMHC. 
(g-h) At 30 dpci, careg:dmKO2 expression declines in the trabecular myocardium, but the 
primordial layer was not fully restored in the regenerated part of the ventricle. (i-j) At 90 dpci, the 
myocardium is completely regenerated, but the expression of careg:dmKO2 is not completely 
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Supplementary Figure 4. careg:dmKO2 is transiently expressed in the peri-injured stump 
during fin regeneration.
(a-l) Live-imaging of careg:dmKO2 fins at different days post-amputation (dpa). Higher 
magnifications of framed areas show the region of the ampulation plane (yellow dashed line). N=4.

























































Supplementary Figure 5. The careg reporter is activated in other injury models of tissue 
regeneration in zebrafish.
(a-d) In-situ hybridization (purple) on longitudinal fin sections reveals that, as in the amputation 
model, the endogenous ctgfa gene is not upregulated in the regenerating fin after cryoinjury. (a, c) 
A probe against a blastema marker, msxb, was used as a positive control to detect the activated 
mesenchyme. (b, d) A ctgfa probe does not label the regenerating fin tissues.  M, mesenchyme; E, 
epidermis. Brackets indicate the damaged tissue remaining at the tip of the cryoinjured stump. N=3.
(e-i) Live-imaging of the larval tail of careg:dmKO2 fish at different days post-fertilization (dpf) 
and post-amputation. The transgenic reporter is constitutively expressed in the notochord. After 
amputation (dashed line), the expression of careg:dmKO2 is markedly upregulated at the tip of the 
regenerating tail. N=6.































































Supplementary Figure 6. Treatment of uninjured organs with the inhibitor of TGFβ/Activin-β 
signalling does not affect the homeostatic expression of careg:EGFP.
(a) Experimental design. Uninjured fish were treated with the inhibitor of TGFβ/Activin-β (20 µM 
SB431542) for 7 days. (b-c) Immunofluorescence staining of uninjured ventricles after 7 days of 
SB431542 treatment. The expression of careg:EGFP in the subcortical layer is similar in control and 
treated fish. (d-e) Longitudinal sections of rays in uninjured fins. Osteoblasts are marked with Zns5 
antibody (red). They cover the surface of acellular bone matrix. In both control and treated 
specimens, careg:EGFP is expressed in intraray osteoblasts, in a few scattered MES and the artery. 
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Supplementary Figure 7. The inhibition of TGFβ/Activin-β signaling suppresses CM 
dedifferentiation and proliferation at the injury-abutting zone during heart regeneration.  
(a-d, f-i) Immunofluorescence staining of ventricles at 7 dpci (a-d) or 14 dpci (f-i) treated with 
DMSO or 20 µM SB431542 labelled with antibodies against fluorescent proteins and embCMHC. 
The intact myocardium is detected by F-actin staining (blue). The upper dotted lines indicate the 
100 µm-thick margin of the myocardium along the injury border. 
(e, j) Percentage of positive myocardium for the careg reporter or embCMHC in a 100 µm-wide 
margin of the regenerating myocardium in control or SB431542-treated hearts. N ≥ 5. ***p < 
0.0001, **p < 0.01, *p < 0.01; unpaired t-test. Error bars correspond to standard error of the mean 
(SEM).
(k-n) Immunofluorescence staining of careg:EGFP ventricle at 7 dpci treated with DMSO or 20 
µM SB431542 labelled with antibodies against GFP (blue), Mef2c (cardiac nuclei, red) and BrdU 
(green). 
(o) Percentage of BrdU+ CMs in a 100 µm-wide margin of the regenerating myocardium in control 
or SB431542-treated hearts. N ≥ 5. ***p < 0.0001; unpaired t-test. Error bars correspond to 


































Supplementary Figure 8. Despite an absence of the regenerative outgrowth, dob mutant fins 
normally induce careg:EGFP in the amputation-activated stump.
(a-f) Live-imaging of careg:EGFP fins at 1 dpa in a wild-type (wt) background treated with DMSO 
or SB431542, and in the fgf20a (dob) mutant background. careg:EGFP expression is suppressed in 
the stump by the inhibition of TGFβ/Activin-β signaling, but it remains normal in fgf20a mutant 
fins. N=4.
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Supplementary Figure 9. Developmental dynamics of careg:dmKO2 expression in the zebrafish 
heart.
(a-c) Longitudinal sections of careg:dmKO2;cmlc2:EGFP transgenic hearts at different time points 
during development,  labelled with DAPI (nuclei, blue) and antibodies against GFP (green, cardiac 
cells) and KO2 (red). (a, b) careg:dmKO2 is expressed in all embryonic cardiomyocytes at 1 and 3 
dpf. (c) At 14 dpf, careg:dmKO2 is maintained in the outer compact layer of the ventricle, whereas 
it is downregulated in the trabecular myocardium. careg:dmKO2 is also expressed in the bulbus 
arteriosus. N ≥ 5. dpf, days post-fertilization; V, ventricle; BA, bulbus arteriosus; A, atrium. 
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Supplementary Figure 10. Control experiments for careg lineage tracing analysis of heart and 
fin regeneration.
(a) Schematic representation of the transgenic strains and the experimental design for lineage tracing 
of careg-expressing primordial CMs during ventricle regeneration. (b-e) Immunostaining of 
uninjured ventricles treated with DMSO or 4-OHT using Tropomyosin (blue).  Exposure to 4-OHT 
for 2 days is sufficient to label primordial CMs with zsYellow, as analysed at 7 days after the 
treatment (-1 day). (f) Schematic representation of the transgenic strains and the experimental design 
for lineage tracing of careg-expressing cells during fin regeneration. (g, h) Longitudinal fin sections 
at 0 and 4 dpa immunostaining for mCherry (red) and Zns5 (green). Exposure to 4-OHT for 1 day 
results in labelling of a few osteoblasts. (i-p) Live imaging of fins at different dpa after treatment with 
4-OHT reveals only a few mCherry labelled cells in the stump and the regenerate. N ≥ 4. 
Supplementary Data 1. The complete list of transcription factor (TF) binding sites within the careg sequence that were predicted with MatInspector 
(Genomatix)                                                                                                                                                  
Selected TF binding sites are schematically represented in Fig. 3c.                                                                                                                                                      
                                                                                                                                                        
Seq. name       Accession no.   Gene symbol     GeneID  Matrix Family   Detailed Family Information     Matrix  Detailed Matrix Information     Tissue  Opt.    
Start position  End position    Anchor position Strand  Core sim.       Matrix sim.     Mat. sim. - opt.        Evidence #      Evidence        Sequence
TempSeq_FZX4oauC                                V$TEAF  TEA/ATTS DNA binding domain factors     V$TEAD.01       "TEA domain-containing factors, 






Urogenital System"      0.9     2       14      8       -       1       0.991   0.091   0               gaaCATTcctcat
TempSeq_FZX4oauC                                V$TALE  TALE homeodomain class recognizing TG motifs    V$TGIF.01       TG-interacting factor belonging to 




Neurons"        1       98      114     106     -       1       0.999   -0.001  0               tgtctggctGTCAaggc
TempSeq_FZX4oauC                                V$ZF11  C2H2 zinc finger transcription factors 11       V$ZBTB3.01      Zinc finger and BTB domain containing 3         
0.95    103     113     108     +       1       0.994   0.044   0               gacaGCCAgac
















Urogenital System"      0.96    123     143     133     +       1       0.99    0.03    0               cctgaccaGGAAgtgacttaa
TempSeq_FZX4oauC                                V$FKHD  Fork head domain factors        V$FOXP1_ES.01   "Alternative splicing variant of FOXP1, activated in 

























Urogenital System"      1       143     159     151     +       1       0.993   -0.007  0               aaaacacAACAtgggat








Thymus Gland"   0.98    155     167     161     -       1       0.996   0.016   0               atttGGGAatccc












Urogenital System"      0.87    243     265     254     -       1       0.996   0.126   0               gcctaaCAATaaggataacaaaa
TempSeq_FZX4oauC                                V$MYT1  MYT1 C2HC zinc finger protein   V$MYT1.02       MyT1 zinc finger transcription factor involved in 
primary neurogenesis  "Central Nervous System
Nervous System
Neuroglia
Neurons"        0.88    397     409     403     +       1       0.992   0.112   0               agaAAGTtttgca











Urogenital System"      0.89    495     507     501     -       1       0.997   0.107   0               tgcTCAGgttact

















Urogenital System"      0.97    498     516     507     -       1       0.994   0.024   0               taattTGAGtgctcaggtt
TempSeq_FZX4oauC                                V$SMAD  Vertebrate SMAD family of transcription factors V$SMAD3.01      Smad3 transcription factor involved 
in TGF-beta signaling       "Embryonic Structures
Kidney
Urogenital System"      0.99    532     542     537     -       1       0.996   0.006   0               tctGTCTggac
























Spinal Cord"    0.97    555     575     565     +       1       0.995   0.025   0               tggtgTAATtgcgcagctatg
TempSeq_FZX4oauC                                V$ZF11  C2H2 zinc finger transcription factors 11       V$ZBTB3.01      Zinc finger and BTB domain containing 3         
0.95    589     599     594     +       1       0.992   0.042   0               ggcaGCCAgat







Pituitary Gland"        1       588     608     598     -       1       0.996   -0.004  0               agagtggTAATctggctgcca
TempSeq_FZX4oauC                                V$CDXF  Vertebrate caudal related homeodomain protein   V$CDX2.03       Caudal type homeobox transcription 
factor 2     "Digestive System
Embryonic Structures"   0.91    641     659     650     -       1       0.99    0.08    0               gaggctgtTTATtgttctc
TempSeq_FZX4oauC                                V$SORY  SOX/SRY-sex/testis determinig and related HMG box factors       V$SOX5.02       SRY-related HMG-











Urogenital System"      0.87    640     662     651     +       1       0.997   0.127   0               agagaACAAtaaacagcctccaa
TempSeq_FZX4oauC                                V$ZFHX  Two-handed zinc finger homeodomain transcription factors        V$ZEB1.01       "Zinc finger E-box 
binding homeobox 1 (AREB6, DELTAEF1)"        Embryonic Structures    0.98    676     688     682     +       1       0.991   0.011   0               cacccACCTgcct
TempSeq_FZX4oauC                                V$TCFF  TCF11 transcription factor      V$TCF11.01      TCF11/LCR-F1/Nrf1 homodimers            1       732     738     
735     +       1       0.998   -0.002  0               GTCAtgt
TempSeq_FZX4oauC                                V$TALE  TALE homeodomain class recognizing TG motifs    V$TGIF.01       TG-interacting factor belonging to 




Neurons"        1       753     769     761     +       1       0.998   -0.002  0               gtgacttctGTCAacag
TempSeq_FZX4oauC                                V$ESRR  Estrogen-related receptors      V$ESRRA.02      Estrogen-related receptor alpha (secondary DNA binding 





Muscles"        0.9     823     845     834     -       1       0.996   0.096   0               tattcactgagaggGGTCaaagg
TempSeq_FZX4oauC                                V$FKHD  Fork head domain factors        V$HNF3.01       "Hepatocyte nuclear factor 3 (alpha, beta) (FOXA1, 

























Urogenital System"      0.98    875     891     883     -       1       0.999   0.019   0               ggacggcAAACagaact
TempSeq_FZX4oauC                                V$TCFF  TCF11 transcription factor      V$TCF11.01      TCF11/LCR-F1/Nrf1 homodimers            1       920     926     
923     +       1       0.994   -0.006  0               GTCAtca












Urogenital System"      0.83    999     1015    1007    -       1       0.996   0.166   0               tgatgtcgTAAAatggt
TempSeq_FZX4oauC                                V$TALE  TALE homeodomain class recognizing TG motifs    V$TGIF.01       TG-interacting factor belonging to 




Neurons"        1       1184    1200    1192    -       1       0.997   -0.003  0               aactttaatGTCAcgct

























Urogenital System"      0.97    1330    1346    1338    -       1       0.992   0.022   0               gctaaatAAACataact
TempSeq_FZX4oauC                                V$HAML  Human acute myelogenous leukemia factors        V$AML1.01       AML1/CBFA2 Runt domain binding 





Skeleton"       0.93    1373    1387    1380    -       1       0.991   0.061   0               ttctGTGGtcaagca












Urogenital System"      0.87    1406    1428    1417    -       1       0.992   0.122   0               cattaaCAATgtgctctgcgtgt
TempSeq_FZX4oauC                                V$TCFF  TCF11 transcription factor      V$TCF11.01      TCF11/LCR-F1/Nrf1 homodimers            1       1480    
1486    1483    -       1       0.993   -0.007  0               GTCAtac
TempSeq_FZX4oauC                                V$CDXF  Vertebrate caudal related homeodomain protein   V$CDX2.03       Caudal type homeobox transcription 
factor 2     "Digestive System
Embryonic Structures"   0.91    1490    1508    1499    -       1       0.99    0.08    0               ttagggttTTATtgagcta














Skeleton"       1       1559    1571    1565    +       1       0.997   -0.003  0               gcaaGATTaggaa
























Spinal Cord"    0.97    1612    1632    1622    -       1       0.997   0.027   0               gtttaTAATtaagatattatc
























Spinal Cord"    0.97    1617    1637    1627    +       1       0.992   0.022   0               tatctTAATtataaacaggaa

















Urogenital System"      0.93    1626    1646    1636    +       1       0.991   0.061   0               tataaacaGGAAataagccac












Urogenital System"      0.87    1661    1683    1672    -       1       0.992   0.122   0               gggtaaCAATatagagaccaatt

















Urogenital System"      0.97    1677    1695    1686    -       1       0.994   0.024   0               tttttTGAGtgggggtaac
TempSeq_FZX4oauC                                V$TCFF  TCF11 transcription factor      V$TCF11.01      TCF11/LCR-F1/Nrf1 homodimers            1       1791    
1797    1794    +       1       0.994   -0.006  0               GTCAtga













Pancreas"       0.97    1848    1870    1859    -       1       0.995   0.025   0               tttgtctgTCAGcaacctctcat
TempSeq_FZX4oauC                                V$TALE  TALE homeodomain class recognizing TG motifs    V$TGIF.01       TG-interacting factor belonging to 




Neurons"        1       1856    1872    1864    -       1       0.998   -0.002  0               gctttgtctGTCAgcaa
TempSeq_FZX4oauC                                V$SORY  SOX/SRY-sex/testis determinig and related HMG box factors       V$SOX6.01       SRY (sex determining 











Urogenital System"      0.97    1861    1883    1872    +       1       0.993   0.023   0               gacagACAAagcatattacaatc




Myocardium"     0.8     1985    2003    1994    +       1       0.992   0.192   0               attcccatatAAGGcaagt





Myeloid Cells"  0.99    2145    2155    2150    +       1       0.992   0.002   0               gaGGGGagtct

















Pituitary Gland"        1       2259    2287    2273    -       1       0.991   -0.009  0               ttacagtgcAGGTgtggtatggttctatt
























Spinal Cord"    0.97    2320    2340    2330    -       1       0.992   0.022   0               ttcttTAATtatatactttca
























Spinal Cord"    0.97    2325    2345    2335    +       1       0.997   0.027   0               gtataTAATtaaagaaaaaca
TempSeq_FZX4oauC                                V$TCFF  TCF11 transcription factor      V$TCF11.01      TCF11/LCR-F1/Nrf1 homodimers            1       2485    
2491    2488    -       1       0.998   -0.002  0               GTCAtgt
TempSeq_FZX4oauC                                V$TALE  TALE homeodomain class recognizing TG motifs    V$TGIF.01       TG-interacting factor belonging to 




Neurons"        1       2515    2531    2523    +       1       0.998   -0.002  0               ccaaattatGTCAttac
TempSeq_FZX4oauC                                V$TCFF  TCF11 transcription factor      V$TCF11.01      TCF11/LCR-F1/Nrf1 homodimers            1       2524    
2530    2527    +       1       0.996   -0.004  0               GTCAtta
TempSeq_FZX4oauC                                V$TALE  TALE homeodomain class recognizing TG motifs    V$TGIF.01       TG-interacting factor belonging to 




Neurons"        1       2715    2731    2723    +       1       0.998   -0.002  0               aacagaattGTCActta
TempSeq_FZX4oauC                                V$HNF6  Onecut homeodomain factor HNF6  V$HNF6.02       Liver enriched Cut - Homeodomain transcription 





Pancreas"       0.86    2771    2787    2779    -       1       0.998   0.138   0               atcataaatCAATaatc















Thymus Gland"   0.85    2773    2789    2781    +       1       0.99    0.14    0               ttattGATTtatgatca














Skeleton" 1 2794 2806 2800 - 1 0.997 -0.003 0  tgatGATTagcag













Pancreas" 0.97 2832 2854 2843 + 1 0.995 0.025 0  gccaaaagTCAGcattattaatt
TempSeq_FZX4oauC    V$RUSH SWI/SNF related nucleophosphoproteins with a RING finger DNA binding motif V$SMARCA3.02 
"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3"  0.98 2931 2941 2936 + 1 
0.993 0.013 0  ctgcACTTtta
TempSeq_FZX4oauC    V$TALE TALE homeodomain class recognizing TG motifs V$TGIF.01 TG-interacting factor belonging to 




Neurons" 1 2948 2964 2956 - 1 0.998 -0.002 0  tcctgggctGTCAcata





Myeloid Cells" 0.99 3004 3014 3009 + 1 0.992 0.002 0  gaGGGGagtgg

















Urogenital System" 1 3143 3161 3152 - 1 0.99 -0.01 0  ggctTGGAgtgttctgatt
